Literature DB >> 3134201

Serological study of subjects with seroconversion to human immunodeficiency virus.

M C Re1, G Furlini, B Baldassarri, F Chiodo.   

Abstract

Twelve homosexual males who seroconverted to human immunodeficiency virus (HIV) were followed-up for over two years. Analysis of sera by immunoblotting showed that seroconversion was characterized by the presence of specific IgM that reacted mainly with viral polypeptides of molecular weights ranging from 17 Kd to 55 Kd. Specific IgG to all HIV proteins was detected. Immunoblotting showed that antibodies to 24 Kd core protein alone or in association with 17 Kd polypeptide appeared first in some cases. Virus antigen was detected in six patients: five subjects were positive at the time of seroconversion, and one became positive afterwards. It is concluded that detection of IgG and IgM antibody against the different viral polypeptides, together with detection of viral antigen is necessary in order to determine the stage of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134201     DOI: 10.1007/bf01963067

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

1.  Serological characterization of HTLV-III infection in AIDS and related disorders.

Authors:  J E Groopman; F W Chen; J A Hope; J M Andrews; R L Swift; C V Benton; J L Sullivan; P A Volberding; D P Sites; S Landesman
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

2.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

3.  Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.

Authors:  J I Esteban; J W Shih; C C Tai; A J Bodner; J W Kay; H J Alter
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

4.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions.

Authors:  J W Curran; D N Lawrence; H Jaffe; J E Kaplan; L D Zyla; M Chamberland; R Weinstein; K J Lui; L B Schonberger; T J Spira
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

5.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

6.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

  6 in total
  3 in total

1.  Biomonitoring Hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG.

Authors:  Adam V Wisnewski; Meredith H Stowe; Abby Nerlinger; Paul Opare-Addo; David Decamp; Christopher R Kleinsmith; Carrie A Redlich
Journal:  Ann Occup Hyg       Date:  2012-03-26

2.  Immunoblotting analysis of IgA and IgM antibody to human immunodeficiency virus type 1 (HIV-1) polypeptides in seropositive infants.

Authors:  M C Re; G Furlini; M Vignoli; G Zauli; P Dallacasa; M Masi; M La Placa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

3.  Antibody response to human immunodeficiency virus after infected bone marrow transplant.

Authors:  G Furlini; M C Re; G Bandini; L Albertazzi; M La Placa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.